Tag: Committee for Medicinal Products
European Commission nod for Pierre Fabre Braftovitovi
Pierre Fabre Laboratories announced that the European Commission (EC) has approved Braftovitovi (encorafenib) in combination with Mektovi (binimetinib) for the treatment of adult patients...